Andrew Talal
Professor of Medicine and Director of the Center for Research and Clinical Care in Liver Disease at State University of New York at Buffalo - School of Medicine & Biomedical Sciences- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Credentials
-
Medical License
New York StateJan, 1996- Oct, 2024 -
Diplomate
National Board of Medical ExaminersJan, 1991- Oct, 2024 -
Diplomate recertification- Gastroenterology
American Board of Internal MedicineJan, 2019- Oct, 2024
Experience
-
-
Professor of Medicine and Director of the Center for Research and Clinical Care in Liver Disease
-
2012 - Present
⇨ Direct externally-funded research programs and in-patient care functions within the internationally-recognized University at Buffalo School of Medicine.⇨ Manage a $2M annual research budget, Department and School of Medicine projects, multi-site research studies, and industry/government funding.⇨ Named Principal Investigator on a $7M, five-year award from the Patient-Centered Outcomes Research Institute. ⇨ Led the development of a Liver Center and associated clinical trials programs that serves the entire Western NY region and the City of Buffalo, an underserved community.⇨ Co-chaired a 2015 conference with the National Institutes of Health (NIH), a major funder of biomedical research in the US. ⇨ Recipient of an administrative supplement from the Center for AIDS Research for the design of a complex study that assessed the effect of liver disease on the metabolism of methadone.
-
-
-
Weill Cornell Medicine
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Assistant and Associate Professor of Medicine
-
2000 - 2012
Oversaw clinical development, clinical trial programs, and research laboratories dedicated to Hepatitis C research. Divided responsibilities between patient care, research, and administration.⇨ Built, from the ground up a liver biorepository, that enabled the collection of samples from patients with diverse forms of liver disease. Started in 2000, the biobank remains in operation to date and recently garnered $1M+ in revenue from sample sale to an industrial partner. ⇨ Established a new liver disease clinical trials program that became a lucrative endeavor for the medical center due to its focus on patients with both HIV and Hepatitis C as well as other forms of liver disease. ⇨ Founded and directed a clinic to include patient populations with difficult to manage liver diseases.
-
-
-
The Rockefeller University
-
United States
-
Research
-
700 & Above Employee
-
Research Associate & Clinical Scholar
-
1996 - 2000
Began research career and honed physician-scientist skills after completing clinical fellowship. ⇨ Obtained first funding from NIH on the first submission, bringing in significant revenue.⇨ Developed the experimental techniques that measured HIV in the tissue lining the gastrointestinal tract. Experimental success led to an increase in external grant funding for the institution.⇨ Significantly increased the institution’s ability to attract industry-sponsored projects by onboarding patients into the invasive research studies.
-
-
Education
-
University of North Carolina at Chapel Hill
Master of Public Health - MPH, Epidemiology -
UT Health San Antonio
Doctor of Medicine - MD, Medicine -
Brown University
Bachelor of Arts - BA